Harrow Health Rg

Harrow, Inc. develops and sells ophthalmic drugs targeting high‑growth eye‑care segments, offering a portfolio of anti‑inflammatory, antibiotic, and steroid agents, plus specialty compounded Rx via ImprimisRx, positioning it for growth in an expanding market.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Hospitals and Health Care
Industry: Medical Practices

Employees: 382
HQ: Nashville

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
HROW	Harrow Health Rg Cap: 1.8B	EQUITY	NMS	USD	US4158581094	Active	📈